» Articles » PMID: 29341790

Postnatal Tendon Growth and Remodeling Require Platelet-derived Growth Factor Receptor Signaling

Overview
Specialties Cell Biology
Physiology
Date 2018 Jan 18
PMID 29341790
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Platelet-derived growth factor receptor (PDGFR) signaling plays an important role in the fundamental biological activities of many cells that compose musculoskeletal tissues. However, little is known about the role of PDGFR signaling during tendon growth and remodeling in adult animals. Using the hindlimb synergist ablation model of tendon growth, our objectives were to determine the role of PDGFR signaling in the adaptation of tendons subjected to a mechanical growth stimulus, as well as to investigate the biological mechanisms behind this response. We demonstrate that both PDGFRs, PDGFRα and PDGFRβ, are expressed in tendon fibroblasts and that the inhibition of PDGFR signaling suppresses the normal growth of tendon tissue in response to mechanical growth cues due to defects in fibroblast proliferation and migration. We also identify membrane type-1 matrix metalloproteinase (MT1-MMP) as an essential proteinase for the migration of tendon fibroblasts through their extracellular matrix. Furthermore, we report that MT1-MMP translation is regulated by phosphoinositide 3-kinase/Akt signaling, while ERK1/2 controls posttranslational trafficking of MT1-MMP to the plasma membrane of tendon fibroblasts. Taken together, these findings demonstrate that PDGFR signaling is necessary for postnatal tendon growth and remodeling and that MT1-MMP is a critical mediator of tendon fibroblast migration and a potential target for the treatment of tendon injuries and diseases.

Citing Articles

Physical and Soluble Cues Enhance Tendon Progenitor Cell Invasion into Injectable Synthetic Hydrogels.

Kent 3rd R, Said M, Busch M, Poupard E, Tsai A, Xia J Adv Funct Mater. 2024; 32(48):2207556.

PMID: 39257859 PMC: 11382351. DOI: 10.1002/adfm.202207556.


Association between Gene Polymorphisms and Platelet-Rich Plasma's Efficiency in Treating Lateral Elbow Tendinopathy-A Prospective Cohort Study.

Jarosz A, Balcerzyk-Matic A, Iwanicka J, Iwanicki T, Nowak T, Szyluk K Int J Mol Sci. 2024; 25(8).

PMID: 38673853 PMC: 11050239. DOI: 10.3390/ijms25084266.


Understanding Tendon Fibroblast Biology and Heterogeneity.

DiIorio S, Young B, Parker J, Griffin M, Longaker M Biomedicines. 2024; 12(4).

PMID: 38672213 PMC: 11048404. DOI: 10.3390/biomedicines12040859.


Comparison of healing of acute total tympanic membrane perforation between rats with and without excision of the mallear handle.

Lou Z, Li C, Yu D, Wang J, Chen Z, Yin S Laryngoscope Investig Otolaryngol. 2023; 8(6):1648-1656.

PMID: 38130269 PMC: 10731538. DOI: 10.1002/lio2.1175.


Biological and Mechanical Factors and Epigenetic Regulation Involved in Tendon Healing.

Li Z, Yang Q, Zhou Y Stem Cells Int. 2023; 2023:4387630.

PMID: 36655033 PMC: 9842431. DOI: 10.1155/2023/4387630.


References
1.
Hellsten Y, Hoier B . Capillary growth in human skeletal muscle: physiological factors and the balance between pro-angiogenic and angiostatic factors. Biochem Soc Trans. 2014; 42(6):1616-22. DOI: 10.1042/BST20140197. View

2.
Couppe C, Kongsgaard M, Aagaard P, Hansen P, Bojsen-Moller J, Kjaer M . Habitual loading results in tendon hypertrophy and increased stiffness of the human patellar tendon. J Appl Physiol (1985). 2008; 105(3):805-10. DOI: 10.1152/japplphysiol.90361.2008. View

3.
Tavares M, Pavan I, Amaral C, Meneguello L, Luchessi A, Simabuco F . The S6K protein family in health and disease. Life Sci. 2015; 131:1-10. DOI: 10.1016/j.lfs.2015.03.001. View

4.
Hiden U, Lassance L, Tabrizi N, Miedl H, Tam-Amersdorfer C, Cetin I . Fetal insulin and IGF-II contribute to gestational diabetes mellitus (GDM)-associated up-regulation of membrane-type matrix metalloproteinase 1 (MT1-MMP) in the human feto-placental endothelium. J Clin Endocrinol Metab. 2012; 97(10):3613-21. DOI: 10.1210/jc.2012-1212. View

5.
Roberts W, Whalen P, Soderstrom E, Moraski G, Lyssikatos J, Wang H . Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 2005; 65(3):957-66. View